Cellular stress protection responses lead to increased transcription of several genes via modulation of transcription factors. Activation of the Nuclear Factor κB (NF-κB) pathway as a possible antiapoptotic route represents one important cellular stress response. To identify conditions that are capable of modifying this pathway, a screening assay for detection of NF-κBdependent gene activation using the reporter protein Enhanced Green Fluorescent Protein (EGFP) and its destabilized variant (d2EGFP) was developed. Human Embryonic Kidney (HEK/293) cells were stably transfected with a vector carrying EGFP or d2EGFP under control of a synthetic promoter containing 4 copies of the NF-κB response element. Treatment with tumor necrosis factor α (TNF-α) gave rise to substantial EGFP/d2EGFP expression in up to 90% of the cells and was therefore used to screen different stably transfected clones for induction of NF-κB-dependent gene expression. The time course of NF-κB activation leading to d2EGFP expression was measured in an oligonucleotide-based NF-κB-ELISA. NF-κB binding increased after 15-min incubation with TNF-α. In parallel, d2EGFP increased after 3 h and reached its maximum at 24 h. These results show (1) the time lag between NF-κB activation and d2EGFP transcription, translation, and protein folding and (2) the increased reporter gene expression after treatment with TNF-α to be caused by the activation of NF-κB. The detection of d2EGFP expression required FACS analysis or fluorescence microscopy, while EGFP could also be measured in the microplate reader, rendering the assay useful for high-throughput screening. (Journal of Biomolecular Screening 2003:511-521) 
INTRODUCTION
T HERE IS A CURRENT AND GROWING NEED to identify conditions or agents that are capable of modifying important cellular signaling pathways. One such pathway in question makes use of the activation of the transcription factor Nuclear Factor κB (NF-κB) in response to inflammation, immunomodulators, and other stressors.
NF-κB belongs to a family of factors characterized by the Rel homology domain, which are sequestered as homo-or heterodimers in the cytoplasm of most cell types, bound to inhibitory proteins of the IκB family. 1 They form 2 subfamilies, those containing activation domains (p65, c-Rel, RelB) and those lacking activation domains (p50, p52). 2 NF-κB was first identified as a protein that binds constitutively to a specific decameric DNA sequence (5′-GGGACTTTCC-3′) within the enhancer of an intron of Immunoglobulin light chain gene in mature B and plasma cells, but not in pre-B cells. 3 The prototypical NF-κB consists of a heterodimer of p65 (RelA) and p50 (NF-κB1). A multitude of cellular stress factors initiates signaling pathways, which lead to phosphorylation of IκB-α and hence to degradation by the proteasome system after ubiquitination. Thus, the nuclear localization signal is uncovered in NF-κB, and it binds to its consensus sequence (5′-GGGRNNNYYCC-3′) in different promoters starting the transcription of NF-κB-dependent genes, which are apoptosis regulating, cell proliferation-dependent, or B-cell proliferative. 4 Tumor necrosis factor α (TNF-α) activates NF-κB by binding to the membrane-integrated TNF-α receptor (TNF-R), which recruits TNF receptor-associated factor 2 (TRAF2). TRAF2 associates with the serine/threonine kinase NF-κB-inducing kinase (NIK), which finally interacts with the IκB kinase (IKK). 5 In the 1990s, the role of NF-κB in the regulation of expression of genes relevant for immune reactions and inflammation was investigated. NF-κB is involved in the regulation of the immunoglobulin κ gene in B lymphocytes and can be activated in pre-B cells by lipopolysaccharide (LPS). 6 NF-κB/Rel activates the transcription of genes involved in the immune response as TNF-α, Interleukin 1α (IL-1α), IL-2, IL-2α-receptor, IL-3, IL-4, IL-6, and interferon-γ 7 and of such genes that control proliferation and suppress apoptosis in many cells. 8, 9 Therefore, importance is attached to this transcription factor in oncogenesis and chemotherapy resistance of several tumors. 10 Besides LPS, a variety of other cellular stress factors such as cytokines, phorbol esters, viruses, ultraviolet radiation, reactive oxygen species, growth factor depletion, hypoxia, heat shock, and ionizing radiation can induce the NF-κB pathway by DNA binding in many cell types. The resulting gene expression can be studied using reporter proteins such as β-galactosidase, luciferase, and secreted alkaline phosphatase (SEAP). These assays are highly sensitive and accurate, but they require addition of a substrate and frequently the preparation of cell lysates.
Expression of Green Fluorescent Protein (GFP), which was originally isolated from the bioluminescent jellyfish Aequorea victoria, 11 represents a unique method for fluorescent labeling of living cells, [12] [13] [14] [15] due to its cofactorless expression in heterologous systems. GFP allows in gene expression studies a "quasi online observation" of cellular processes in individual living cells. Contrary to "Enhanced GFP" (EGFP), which is extremely stable, its variant form "destabilized EGFP" (d2EGFP) has a reduced halflife of about 2 to 3 h. 16 Therewith, it allows a more precise measurement of transient gene activation. These properties render EGFP and d2EGFP ideal candidate reporter proteins for studies of gene expression under extreme experimental conditions, such as space flight experiments, and in response to heavy ions exposure, and other applications which require minimization of liquid handling and sample preparation. Furthermore, EGFP and d2EGFP allowing analysis of individual living cells make them superior for single-cell applications, such as determination of the bystander effect in microbeam experiments, compared to other reporters such as luciferase, which is determined in cell lysates and to SEAP, which is measured in cell culture supernatants.
Several NF-κB activation assays using reporter proteins, such as luciferase, SEAP, and EGFP/dEGFP, have been described. 17, 18 These assays utilize transient transfections. In this study, the usefulness of stably transfected clones for monitoring the NF-κB activation under several conditions is shown. Vectors coding for EGFP/d2EGFP genes under control of a synthetic promoter containing 4 tandem copies of the κB enhancer element (κB 4 ) are integrated into the DNA of a human cell line. Activation of the pathway leads to binding of the endogenous NF-κB to the κB enhancer element, which is located upstream of the reporter gene on the vector, and thereby it increases the transcription of EGFP/d2EGFP. TNF-α as a known NF-κB activator is used to screen stably transfected clones for NF-κB-dependent EGFP/d2EGFP expres-sion. The time course of NF-κB activation was determined by 2 independent methods: (1) increased gene expression was measured fluorimetrically by means of the d2EGFP, (2) activation of NF-κB and its binding to the κB-consensus site was measured in an oligonucleotide-based NF-κB-ELISA via immune reaction. EGFP/d2EGFP fluorescence is measured by flow cytometry, which provides single-cell information, and in a microplate fluorimeter showing the usefulness of the clones stably transfected with the EGFP construct for high-throughput screening (HTS).
MATERIALS AND METHODS

Materials
Human recombinant TNF-α and bovine serum albumin (BSA) were obtained from Sigma-Aldrich Chemie, Steinheim, Germany.
Cells and culture conditions
Human embryonic kidney (293/HEK) cells were obtained from the American Type Culture Collection, Manassas, VA (ATCC CRL-1573). Cells were cultured according to standard procedures in 80 cm 2 flasks (Nunc, Wiesbaden, Germany) in α-medium (modified MEM, Biochrom KG, Berlin, Germany) with 10% fetal bovine serum (FBS) at 37°C, saturated humidity and a 5% CO 2 / 95% air atmosphere. Cultures were split (1:40) every 7 days using standard trypsination procedures (0.05% trypsin containing 0.02% EDTA solution; Biochrom KG, Berlin, Germany). Medium was changed after 4 days.
Plasmid cloning and preparation
The plasmids pEGFP-1, pNF-κB-d2EGFP, and pd2EGFP-1 were obtained from BD Clontech, Palo Alto, CA. The vectors pEGFP-1 and pd2EGFP-1 are promoterless, whereas in the vector pNF-κB-d2EGFP, the d2EGFP gene is controlled by a synthetic promoter consisting of 4 κ enhancer elements (κB 4 = 4 NF-κB response elements) and the thymidine kinase minimal promoter. pEGFP-1 and pd2EGFP-1 contain a G418 resistance gene for stable transfection. Small-scale preparations of DNA for cloning were prepared using the Wizard Miniprep Kit (Promega, Mannheim, Germany), according to the protocol recommended by the supplier. The plasmid pNF-κB-d2EGFP/Neo was constructed from the d2EGFP-less vector backbone of pd2EGFP-1 and the κB binding site and d2EGFP gene stretch excised from the vector pNF-κB-d2EGFP following standard procedures. 19 The plasmid pNF-κB-EGFP/Neo was constructed from the d2EGFP-less vector pNF-κB-d2EGFP/Neo and the EGFP gene stretch excised from the vector pEGFP-1. The resulting ligation products were identified by restriction analysis. Escherichia coli DH5α were transformed with the different plasmids, and large-scale plasmid preparations were performed using a Qiagen Maxiprep Kit (Qiagen, Hilden, Germany). DNA concentrations were measured in a Hitachi spectrophotometer (optical density at 260 nm).
Transfection
HEK cells were transfected with pNF-κB-d2EGFP/Neo and pNF-κB-EGFP/Neo by lipid mediated DNA transfer (FuGene 6, Boehringer Mannheim, Germany) in the presence of 10% FBS. Semiconfluent cells already grown for 3 days were incubated in 24-well plates in the presence of the DNA-lipid complexes according to the suppliers' instructions. On the next day, the medium was replaced by fresh medium, and 48 h after transfection, cells were split 1:10 in Petri dishes and the aminoglycoside antibiotic G418 (Calbiochem-Novabiochem, Schwalbach, Germany) was added to the medium (1.5 mg/ml). After 10 days, G418-resistant cells were seeded in microplates at a concentration of 50 cells per plate and cultivated for 10-20 days. The resulting colonies were screened for inducible d2EGFP/EGFP expression: cells were split and seeded into two 24-well plates, and 1 plate was treated with 0.6 nmol/l TNF-α at 60%-80% confluence. A prescreening in the fluorescence microscope 18 h later was followed by FACS analysis. The stably transfected clones were maintained in medium containing 1.5 mg/ml G418.
Fluorescence microscopy
For stable transfection, the colonies were screened for d2EGFP/EGFP expression using an Axiovert 135 inverted microscope (Carl Zeiss, Oberkochen, Germany) equipped with a filter set suitable for fluorescein detection (Filter Set 9, excitation BP 450-490 nm, emission LP 520 nm).
Fluorescence measurements using a microplate reader
The d2EGFP/EGFP fluorescence was read in the microplate reader Lambda Fluoro 320 (MWG Biotech, Ebersberg, Germany) using the 5 mm optical probe from bottom position without temperature control and without shaking. The high-quality interference filter set 460/40 × 508/20 was adjusted for measuring EGFP. 14 
Flow cytometry
Samples of stably transfected clones and cells treated with different agents were prepared as follows: cells were harvested by trypsination and fixed with cold 3.5% formaldehyde in phosphatebuffered saline (PBS) for 30 min at 4°C. The fixative was diluted with PBS (1:3), and cells were stored at 4°C. Before FACS analysis, cells were centrifuged and resuspended in PBS. Forward and sideward scatter as well as green fluorescence of the samples were measured in a FACScan (Becton Dickinson, San Jose, CA) with an argon laser (488 nm) as excitation source. 2 × 10 4 cells were analyzed at a rate of 200-600 cells per second. CellQuest software (version 1.2, Becton Dickinson) was used for data analysis. The markers M1 (EGFP(-)) and M2 (EGFP(+)) were set by means of untreated and TNF-α-treated HEK-pNF-κB-d2EGFP/Neo clone L2 cells. The population fractions displaying fluorescence intensities in the zone of marker M2 (EGFP(+)-cells) were used as a measure of induction.
Treatment with TNF-
Stably transfected cells were seeded into 24-well plates or 96well plates at 5 × 10 4 cells/cm 2 and grown for 4 days before treatment. TNF-α, dissolved in PBS containing 1% BSA, was added in medium containing 10% serum. Cells were harvested for FACS analysis after different time intervals.
Measurement of NF-B activation
Cells were seeded into Petri dishes (∅ 6 cm), incubated for 3 days, and treated with 0.6 nmol/l TNF-α if not indicated otherwise in cell culture medium containing 10% FBS. One Petri dish per incubation time was harvested by trypsination for FACS analysis. Another Petri dish was washed with ice-cold PBS, cells were scraped in 3 ml PBS, centrifuged, lysed using the lysis buffer provided by the TransAM™ supplier and stored at -80°C until analysis. Protein concentration was determined by the Bio-Rad's protein assay (Bio-Rad Laboratories, München, Germany), based on the Bradford dye-binding procedure. Activated NF-κB in the cell lysates (adjusted for 7.5 µg total protein) was measured using the NFκB p65 Transcription Factor Assay Kit (TransAM™, Active Motif Europe, Rixensart, Belgium), containing an oligonucleotide with a NF-κB consensus binding site for p65 dimers (5′-GGGACTTTCC-3′). Results were expressed as optical density measured at 450 nm per µg protein. As internal controls (1) a HeLa extract with activated NF-κB provided by the supplier was used and (2) lysates were incubated with mutated and wild-type oligonucleotides. The experiments were repeated 3 times.
Statistical analysis
The Z′ factor for the microplate version of the assay was calculated for the clones H3, H6, and L2 for the time point 78 h after addition of TNF-α according to the following formula:
Background fluorescence of media and microplate was subtracted before calculation of means and standard deviations (SD).
RESULTS
Stable transfection
To quantitate NF-κB-dependent transcriptional activation in response to several stimuli in human cells, the reporters EGFP and d2EGFP were used. The vectors pNF-κB-d2EGFP/Neo and pNF-κB-EGFP/Neo were cloned ( Fig. 1) , their identity was controlled by restriction analysis (Fig. 2 and Table 1 ), and they were stably transfected into Human Embryonic Kidney (HEK/293) cells.
From the stably transfected clones, such were selected which showed an increased d2EGFP/EGFP expression after treatment with the NF-κB-activator TNF-α. For that purpose, the dose response of d2EGFP expression for 2 different time points after addition of TNF-α was determined for 1 d2EGFP-expressing clone ( Fig. 3) . A concentration as low as 30 pmol/l TNF-α induces more than 50% of the maximal expectable response. From these results, it was decided to use 600 pmol/l TNF-α for selection of clones and as a positive control for NF-κB activation. Low and high serum (0.2 or 10% FBS) concentration had no influence on NF-κB activation in HEK cells by TNF-α (data not shown).
From 40 HEK-pNF-κB-d2EGFP/Neo clones, 25 were not inducible, 8 clones showed strong and 7 clones weak d2EGFP expression after TNF-α treatment. Figure 4 depicts histograms obtained by FACS analysis. After 18 h incubation with TNF-α, clones L1 and L2 exhibit a strong increase in fluorescence intensity, and more than 60% of the population are EGFP(+). There is no substantial induction of d2EGFP expression for both clones by the solvent alone (1% BSA in PBS) ( Fig. 4 B,C) . Clone L7 shows no increase in d2EGFP expression after TNF-α treatment (Fig.  4A ). Because of its high fluorescence signal, clone L2 was selected for further experiments.
From 65 HEK-pNF-κB-EGFP/Neo clones, 4 were inducible (2 are shown in Fig. 4E-F) , the others were not inducible with either no EGFP expression at all (15 clones) or EGFP expression independent of TNF-α exposure (46 clones, Fig. 4D ). Because of their low background and their high fluorescence during TNF-α treatment, clones H3 and H6 were selected for further experiments (Fig. 4E-F) .
Activation of NF-B
To investigate a crucial step in the pathway that starts with binding of TNF-α to the TNF receptor in the cell membrane leading finally to the increased d2EGFP expression, the activation of NF-κB was verified by means of an oligonucleotide-based NF-κB-ELISA (NFκB p65 Transcription Factor Assay Kit). As early as after 15 (Fig. 1) . pNF-κB-d2EGFP/Neo, pEGFP-1, and the ligation products were digested with the restriction enzymes PstI, NheI and Bsp119I and MluI (expected results in Table 1) , HindIII, and EcoRI (results not shown). M marker KiloBase™ (Pharmacia), P1 pNF-κB-d2EGFP/Neo, P2 pEGFP-1, L ligation product. Arrow indicates 129 bp fragment of Bsp119I digested ligation product. min incubation with TNF-α, an increased NF-κB binding to the oligonucleotide (κB binding sequence) was demonstrated. Binding increased for a further 45 min and continued on a high level for several days (Fig. 5B ). After 12 h incubation, a nonspecific binding reaction can be detected in untreated cells (PBS 1% BSA). Controls incubated with a mutated κB site oligonucleotide show no competition in p65 binding in treated and untreated cells, whereas addition of an excess amount of wild-type oligonucleotide leads to a decrease of almost 40% in treated but not in untreated cells, suggesting a completely nonspecific binding reaction in untreated and a partly nonspecific binding in treated cells for incubation longer than 12 h with TNF-α ( Fig. 5C ). This nonspecific binding is not present in cells treated less than 12 h and in the TNF-α-treated HeLa extract provided by the supplier (which does not allow time-dependent measurements as it represents only 1 time point after TNF-α treatment). 
Kinetics of d2EGFP/EGFP expression after treatment of stably transfected HEK cells with TNF-
Likewise to NF-κB binding, but with a time delay, an increased d2EGFP expression can be shown by FACS analysis starting after 3 h, and reaching its maximum after 6 to 24 hours. d2EGFP expression remains as well on a high level for several days, with 50% of the cells expressing d2EGFP (Fig. 5A) . In control cells treated with PBS containing 1% BSA, only 4% to 6% of the cell population show a d2EGFP expression.
Eighty percent to 90% of the population of the 2 clones examined (HEK-pNF-κB-EGFP/Neo H3 and H6) showed EGFP expression after induction with TNF-α. Compared to d2EGFP, EGFP expression composes a larger part of the population. The decrease in the number of EGFP(+) cells following the peak value at 24 h is very low in clone H3, and more pronounced in clone H6 (Fig. 6 ).
Comparison of d2EGFP and EGFP as reporter genes
After treatment with TNF-α, HEK-pNF-κB-d2EGFP/Neo clones emit lower absolute fluorescence compared to EGFPexpressing cells (HEK-pNF-κB-EGFP/Neo) measured with the FACScan (Fig. 4B-C, Fig. 4E-F) . Because in inducible HEK-pNF-κB-EGFP/Neo populations about 5% to 20% of cells show EGFP fluorescence already before treatment, whereas in HEK-pNF-κB-d2EGFP/Neo clone L2, less than 3% of cells are positive, the induction range (defined is EGFP-positive cells in treated versus untreated samples) is greater for d2EGFP than for EGFP. Two different clones of HEK-pNF-κB-EGFP/Neo were tested for measurement of induced EGFP expression using the microplate reader. Compared to HEK-pNF-κB-d2EGFP/Neo clone L2 (expressing d2EGFP), both clones exhibit a fluorescence increase after addition of TNF-α, and a decrease to background fluorescence after 8 days for clone H6. Clone H3 does not decline to background fluorescence values even after 10 days (Fig. 7) .
DISCUSSION
The transcription factor NF-κB (nuclear factor κB) is a key component for the inducible expression of a wide variety of cellular genes. Therefore, accurate monitoring of NF-κB activation in cells, tissues, or animals is crucial for drug development and signal transduction pathway studies. To date, such research projects are time consuming and tedious and lack HTS systems. It was the aim of the current study to develop a mammalian screening assay for quick and reliable measurements of cellular NF-κB signal transduction. For that purpose, we decided to make use of a recombinant assay system that is based on the receptor-reporter principle. This system consists of human cell lines transfected with plasmids where the expression of EGFP or its destabilized variant d2EGFP is controlled by a synthetic promoter containing NF-κB binding sequences as enhancer elements. By that, it is possible to quantify NF-κB-dependent transcriptional activation in response to several stimuli in human cells simply by measuring the yields of green fluorescence of the reporter protein.
Assays of such kind are frequently done by transient transfections of reporter plasmids into recipient cells, followed by determination of the fraction of responding cells after stimulation. However, this is a time-and labor-consuming procedure and requires optimization of transfection efficiency. To minimize experimental effort, we preferred to produce stably transfected cell lines. For that we had to construct vectors containing the following gene stretches as functional elements: (1) four copies of the decameric NF-κB binding element (κB 4 ) as part of a synthetic promoter, (2) EGFP or d2EGFP sequences for reporter protein synthesis, and (3) the kanamycin/neomycin resistance gene transferring G418 resistance to transformed cells. Starting from the 3 plasmids pEGFP-1, pd2EGFP-1, and pNF-κB-d2EGFP, commercially available from BD Clontech, we excised the gene stretches necessary to design the desired plasmids pNF-κB-EGFP/Neo and pNF-κB-d2EGFP/Neo (Fig. 1, Fig. 2) . These plasmids were used for transfection of human cells. The selection of the cell line to be used for activation of NF-κB is critical, insofar as the amount of activation differs considerably between various established cell lines positive for this signal transduction pathway. 7, 20 In some cell types such as mature B cells, monocytes, macrophages, neurons, cornea keratinocytes, and smooth muscle cells, NF-κB is constitutively active. 21 Human cell lines having a high NF-κB activating response are, for example, osteoblast-like cells, 22 some T-cell lines, 23, 24 macrophage-derived cell lines, 25 and HEK/293 cells. 26 As the HEK/293 cell line allows for adherent growth with a suitable doubling time, HEK cells were chosen as recipient cells for transfection experiments using the NF-κB-activation reporter vectors.
TNF-α was used as a positive inducer of NF-κB activation in these cells. It is known to activate NF-κB in such cells that express the surface TNF receptor 1 (TNF-R-1), 4 and it induces, for example, in cells of the immune system the expression of genes having a κB-site in their promoter. 27 It provokes apoptosis in some cell types. 28, 29 In other cell types, it seems to stimulate cellular survival by activation of NF-κB. 9, 5, 30, 31 Stable transfection of HEK/293 cells was performed with the vectors constructed in our lab by lipid-mediated DNA transfer followed by selection for neomycin resistance with the antibiotic G418. This method reaches a good transfection frequency; however, the level and stability of the marker gene's expression is affected by both chromosomal position effects and the number of integration events. 32 Accordingly, EGFP expression can be low or even absent, if either the vector is integrated in an inactive part of the genome or its linearization by cellular enzymes results in the destruction of function-relevant parts of the vector, such as the promoter, the EGFP gene, or the neomycin resistance gene. This may account for noninducible clones (Fig. 4A ) and requires the screening of multiple resistant clones for their inducible d2EGFP or EGFP expression. On the other hand, EGFP expression can already be very high in absence of a suitable inducer, if a vector having a destroyed promoter region comes under the control of a strong cellular promoter after integration of the plasmid into a cellular chromosome. In such cells with high constitutive background EGFP fluorescence, the NF-κB-pathway is not inducible (Fig.   4D ). In some inducible HEK-pNF-κB-d2EGFP/Neo clones, a higher basal green fluorescence compared to noninducible clones can be detected, which can be explained by an activation of the NF-κB pathway in a small percentage of the population. From the results shown in Figure 4 , suitable clones (HEK-p-NF-κB-d2EGFP/ Neo clone L2, HEK-p-NF-κB-EGFP/Neo clones H3 and H6) were selected for further experiments.
To investigate the mechanism and time course of NF-κB activation in TNF-α-treated HEK cells, 2 experimental approaches were chosen: (1) measurement of the liberation of the NF-κB p65 subunit from the NF-κB/IκB-α complex using an ELISA kit and (2) the function of activated NF-κB to act as a transcription factor via induced EGFP expression.
The NF-κB-ELISA reports binding of activated NF-κB contained in cell extracts to immobilized oligonucleotides having a NF-κB consensus binding site, followed by immune-chemical evidence using anti-p65 antibodies. Experiments with wild-type and mutated oligonucleotides ( Fig. 5C ) proved p65 to be part of the activated NF-κB dimer in extracts of TNF-α-treated HEK cells. This is in line with findings of Nelson et al. 33 that p65 and IκB-α are the true substrates for TNF-α stimulation in HeLa cells.
The results obtained by the NF-κB-ELISA show p65 binding to be induced as early as 15 min after addition of TNF-α. Thereafter, binding increases for up to 96 h (Fig. 5B ). Data obtained by FACS analysis of treated HEK-p-NF-κB-d2EGFP/Neo cells shows d2EGFP expression to be detectable after 3 h and to reach its full extent after 6 h. The time lag of 165 min between NF-κB-activation (ELISA measurements) and recording of green fluorescence (FACS analysis) is obviously attributable to transcription, translation, protein folding, and maturation of d2EGFP. Thus, we assume increased reporter gene expression after treatment with TNF-α to be caused by the activation of NF-κB.
The fluorescent reporter technology using green fluorescent protein or its variants as reporter molecule allows in vivo analysis of gene expression. As the fluorescence signal can be taken from the living cell, the measurement is nondestructive for the test cells. Fluorescence data of the test cells can be continuously monitored during the incubation period. This would allow to record the whole time kinetics for NF-κB activation from the same cells.
In this respect, it is of great value to characterize the suitability of different EGFP variants as reporter molecules for assays of this kind. It has been shown that the variant of choice for examining the dynamic response of inducible cellular promoters and enhancer elements is d2EGFP, 16, 15, 34 which carries a PEST amino acid sequence that targets the protein for degradation and results in rapid protein turnover. 35 The resulting protein half-life of approximately 2 to 3 hours allows kinetic measurements of gene expression modulations (up/down regulation). Results from FACS analysis for TNF-α-induced NF-κB activation shows for HEK-p-NF-κB-d2EGFP/Neo (clone L2) up to 60% cells positive for EGFP fluorescence for about 24 h of incubation and a decrease thereafter, resulting in about 30% of positive cells for the 72-h incubation period. Similar experiments with HEK-pNF-κB-EGFP/Neo cells, Fluorescent NF-κB Activation Reporter Assay expressing the stabile EGFP variant, resulted in about 80% and 90% EGFP-positive cells after 24 h for clone H6 and H3, respectively. For the 72-h incubation period, the fraction of EGFPpositive cells is rather high, about 70% for clone H6 and 90% for clone H3, reflecting the fact that the stabile variant is of negligible use for measurements of gene expression fluctuations.
Due to the low accumulation of d2EGFP from inducible promoters, d2EGFP cannot be visualized using a microplate reader (Fig. 7) . Its detection requires the use of highly sensitive methods, such as FACS analysis. This in turn accounts for single measurements of multiple samples, resulting in high demands of supplies and manpower. Thus, d2EGFP is not useful for HTS. EGFP, however, is a useful alternative for microscale gene activation assays using a microplate reader, especially after background optimization. 14, 15 A microscale assay offers the advantage to measure the same batch of cells repeatedly after different time periods (Fig. 7) , a fact that is mandatory for most kinetic measurements. Although the dynamic range for EGFP measurements with the microplate reader is quite low, we observed a doubling of fluorescence yields in TNF-α-treated cells. The time course of EGFP expression, however, differs in its parameter values from the time course of FACS measurements. This is due to the fact that the long-living EGFP variant accumulates to a much greater amount within the cells than does destabilized d2EGFP. This in turn accounts for a shift of the peak value for EGFP fluorescence to later time points, due to a much larger protein half-life (< 24 h) than maturation time (~3 h). The presented FACS data comprise the percentage of EGFP positive cells, but not their mean fluorescence, which reaches a maximum at 48 h after addition of TNF-α. Furthermore, FACS analysis provides single cell measurements, whereas in the microplate reader, fluorescence of the whole cell layer is measured. In this respect, it has to be considered that the cells divide about 2 times in presence of TNF-α during the measurement period of 96 h, providing an increase in fluorescence intensity per well. Thus, a decrease in fluorescence cannot be measured until gene expression decreases markedly. The Z′ factor, describing the robustness and reproducibility of an assay, ranges from 0.5 to 1 for the EGFPexpressing clones (clone H6 0.85, clone H3 0.51) and is 0 or less for the d2EGFP-expressing clone L2. Accordingly, this assay design, using the stabile EGFP variant, is useful for screening of NF-κB-dependent gene activation in the microplate format, especially if only upregulation has to be considered. This is of special interest for drug development and signal transduction studies, where huge numbers of agents have to be checked within a short time.
Our results are in line with findings by Indraccolo et al., 36 who established a system to study the activity of cis-acting cellular regulatory sequences in cell lines and primary cells, using EGFP and d2EGFP. They detected only the activity of strong retroviral enhancers such as the Moloney murine leukemia virus enhancer. Relatively weak CD2 and Tie2 enhancers required monitoring by EGFP. Comparable results were found by Pol et al. 37 for a secreted EGFP fusion protein under control of the endogenous, TNF-αinducible promoter of the SKALP/elafin gene.
CONCLUSIONS
We developed an assay for NF-κB activation on exposure of cells to different stressors using the reporter genes d2EGFP and EGFP. Our studies exhibit that the increased reporter gene expression in consequence of treatment with stressors in a mammalian cell line stably transfected with a NF-κB binding site-controlled reporter plasmid is dependant upon the activation of the transcription factor NF-κB. The comparison of the reporter proteins d2EGFP and EGFP in stably transfected cells has shown that d2EGFP is especially valuable for the examination of up-and downregulation of gene expression by means of flow cytometry and that EGFP is applicable for rapid screening of gene activation (only upregulation) in the microplate format.
